| Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients C Blimark, E Holmberg, UH Mellqvist, O Landgren, M Björkholm, ... haematologica 100 (1), 107, 2015 | 547 | 2015 |
| Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study SY Kristinsson, RM Pfeiffer, M Björkholm, LR Goldin, S Schulman, ... Blood, The Journal of the American Society of Hematology 115 (24), 4991-4998, 2010 | 290 | 2010 |
| Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden O Landgren, SY Kristinsson, LR Goldin, NE Caporaso, C Blimark, ... Blood, The Journal of the American Society of Hematology 114 (4), 791-795, 2009 | 201 | 2009 |
| Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial UH Mellqvist, P Gimsing, O Hjertner, S Lenhoff, E Laane, K Remes, ... Blood, The Journal of the American Society of Hematology 121 (23), 4647-4654, 2013 | 180 | 2013 |
| Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study SY Kristinsson, M Tang, RM Pfeiffer, M Björkholm, LR Goldin, C Blimark, ... haematologica 97 (6), 854, 2012 | 157 | 2012 |
| Rapidly changing myeloma epidemiology in the general population: Increased incidence, older patients, and longer survival I Turesson, M Bjorkholm, CH Blimark, S Kristinsson, R Velez, O Landgren European journal of haematology 101 (2), 237-244, 2018 | 151 | 2018 |
| Outcome and survival of myeloma patients diagnosed 2008–2015. Real-world data on 4904 patients from the Swedish Myeloma Registry CH Blimark, I Turesson, A Genell, L Ahlberg, B Björkstrand, K Carlson, ... haematologica 103 (3), 506, 2018 | 144 | 2018 |
| Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study SY Kristinsson, M Björkholm, TML Andersson, S Eloranta, PW Dickman, ... haematologica 94 (12), 1714, 2009 | 142 | 2009 |
| Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study SY Kristinsson, M Tang, RM Pfeiffer, M Björkholm, C Blimark, UH Mellqvist, ... Blood, The Journal of the American Society of Hematology 116 (15), 2651-2655, 2010 | 133 | 2010 |
| Dramatically improved survival in multiple myeloma patients in the recent decade: results from a Swedish population-based study S Thorsteinsdottir, PW Dickman, O Landgren, C Blimark, M Hultcrantz, ... Haematologica 103 (9), e412, 2018 | 126 | 2018 |
| Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study EK Lindqvist, LR Goldin, O Landgren, C Blimark, UH Mellqvist, I Turesson, ... Blood, The Journal of the American Society of Hematology 118 (24), 6284-6291, 2011 | 117 | 2011 |
| Patterns of hematologic malignancies and solid tumors among 37,838 first‐degree relatives of 13,896 patients with multiple myeloma in Sweden SY Kristinsson, M Björkholm, LR Goldin, C Blimark, UH Mellqvist, ... International journal of cancer 125 (9), 2147-2150, 2009 | 106 | 2009 |
| Secondary immunodeficiency in lymphoproliferative malignancies V Friman, O Winqvist, C Blimark, P Langerbeins, H Chapel, F Dhalla Hematological oncology 34 (3), 121-132, 2016 | 89 | 2016 |
| Incidence, characteristics, and outcome of solitary plasmacytoma and plasma cell leukemia. Population‐based data from the Swedish Myeloma Register H Nahi, A Genell, G Wålinder, K Uttervall, G Juliusson, F Karin, ... European journal of haematology 99 (3), 216-222, 2017 | 71 | 2017 |
| Treatment for high-risk smoldering myeloma SY Kristinsson, E Holmberg, C Blimark The New England journal of medicine 369 (18), 1762-1763, 2013 | 69 | 2013 |
| Percutaneous vertebroplasty at C2: case report of a patient with multiple myeloma and a literature review M Rodriguez-Catarino, C Blimark, J Willén, UH Mellqvist, S Rödjer European Spine Journal 16 (Suppl 3), 242-249, 2007 | 61 | 2007 |
| Improved survival in myeloma patients: starting to close in on the gap between elderly patients and a matched normal population J Liwing, K Uttervall, J Lund, A Aldrin, C Blimark, K Carlson, J Enestig, ... British journal of haematology 164 (5), 684-693, 2014 | 60 | 2014 |
| Survival in multiple myeloma patients who develop second malignancies: a population-based cohort study G Jonsdottir, SH Lund, M Björkholm, I Turesson, A Wahlin, S Mailankody, ... Haematologica 101 (4), e145, 2016 | 35 | 2016 |
| Improved progression free survival with bortezomib consolidation after high dose melphalan: results of a randomised phase III trial UH Mellquist, P Gimsing, O Hjertner, S Lenhoff, E Laane, K Remes, ... 13th International Meoloma Workshop, 2011 | 34 | 2011 |
| Comorbidities in multiple myeloma and implications on survival: a population‐based study IS Sverrisdóttir, S Rögnvaldsson, S Thorsteinsdottir, GK Gíslason, ... European journal of haematology 106 (6), 774-782, 2021 | 26 | 2021 |
Sigurður Yngvi KristinssonFaculty of Medicine, University of Iceland and Department of Hematology, Landspitali National在 hi.is 的电子邮件经过验证
